Abstract: A method for predicting treatment response of a type II diabetes patient to rosiglitazone is provided. The method involves at least one sample from a patient having type II diabetes and analyzing biomarkers predictive of a patient who will respond to treatment with rosiglitazone. The biomarkers include, at least, interleukin-8, histidine, citrate. These biomarkers are identified in at least one classification analyses selected from the group consisting of a majority-vote based classifier and support-vector machine (SVM) classifier. Also provided is a method for predicting treatment response of a type II diabetes patient to glyburide at 8 weeks post-initiation of therapy. The method involves obtaining a sample from a type II diabetes patient who has been treated with glyburide for about 4 weeks and analyzing biomarkers predictive of a patient who will respond to treatment with glyburide at 8 weeks. The biomarkers useful in this method include, at least, sphingomyelin 23:1 and L-phenylalanine.

Abstract: To enable a user to readily determine the gauge of the needle of a needle assembly that has a base and a needle protective housing pivotably attached thereto, the needle assembly is injection molded from a color coded molding material which color was preassigned to correspond to the gauge of the needle. As a result, both the base and the protective housing of the needle assembly are the same specific color, and reflect or provide an indication of the given gauge of the needle. The needle sheath that covers the needle prior to use may be made of a plastics material that may be clear, or have the same or a different color than that of the needle assembly.

Abstract: A computer readable storage medium comprises a publication definition module to create and define properties for a publication object. The publication definition module includes executable instructions to associate a set of static documents and a set of report templates with the publication object. Executable instructions define a conditional delivery rule for the publication object. The conditional delivery rule specifies a condition for the inclusion of a report template from the set of report templates to be merged with a static document from the set of static documents.

Abstract: A safety device to be used with a vial, or capsule, has a collar dimensioned to slidably fit about the body of the vial. Extending from the collar is a neck member that has connected to its other end a housing pivotable to a position along the longitudinal axis of the vial. A latch member having a lip is integrated to the neck member and extends out from the neck member in a direction towards the center of the collar. Neck member is fabricated to have an elastic characteristic so that if it is not biased by any external force, it will return to its original position. As the collar of the safety device is moved along the body of the vial, neck member is biased away from the vial as the latch member maintains contact along the outer surface of the vial, and then the outer surface of the hub formed at the top end of the vial.

Abstract: To enable a user to readily determine the gauge of the needle of a needle assembly that has a base and a needle protective housing pivotably attached thereto, the needle assembly is injection molded from a color coded molding material which color was preassigned to correspond to the gauge of the needle. As a result, both the base and the protective housing of the needle assembly are the same specific color, and reflect or provide an indication of the given gauge of the needle. The needle sheath that covers the needle prior to use may be made of a plastics material that may be clear, or have the same or a different color than that of the needle assembly.

Abstract: The present invention safety device is a one-piece needle assembly that has a base and a housing pivotally connected to the base. The base has a distal portion to which a needle is fitted. At the base there is formed longitudinally along its distal portion a catch mechanism that may be in the form of an anchor projection. At the back wall of the housing there is extended another catch mechanism that may be configured in the form of two clasping fingers. Also providing in the housing is an integral hook. As the housing and the base are pivoted relative to each other, and as the needle makes contact with the hook, the respective catch mechanisms at the base and the housing also make contact with each other, resulting in the coupling of the catch mechanisms and the coupling of the needle to the hook. As a result, the catch mechanisms are interlocked and the needle is fixedly retained by the hook within the housing.

Abstract: A method for the identification of agents for use in the treatment of metabolic diseases, disorders or conditions, for example obesity and diabetes, or for causing weight loss without substantial adverse health effects, in an animal in need of such treatment, comprises the step of identifying an agent that modulates ATP production or content in the hypothalamus of an animal.

Abstract: A fluid transfer system has a holder that is made of a cylindrical member having a closed end and an open end. The closed end has fitted thereto a luer and a cannula that extends into the interior of the holder. The holder has a distal portion that has a first cross section and a proximal portion that has a second cross section. The cross section of the distal portion is smaller than the cross section of the proximal portion. The distal and proximal portions are joined by a shoulder. The fluid transfer system also includes an adapter that is inserted to the holder from the open end of the holder. The adapter has a base having a central opening and a cylindrical tube that extends from the central opening. The diameter of the cylindrical tube is slightly smaller than the diameter of the distal portion and is configured to accept a first type of fluid collection store such as a vacuum tube.

Abstract: The present invention concerns the treatment of andropause and related conditions using a combination of an estrogen agonist/antagonist and testosterone.

Abstract: The present invention relates to methods of treating pulmonary hypertension, facilitating joint fusion, facilitating tendon and ligament repair, reducing the occurrence of secondary fracture, treating avascular necrosis, facilitating cartilage repair, facilitating bone healing after limb transplantation, facilitating liver regeneration, facilitating wound healing, reducing the occurrence of gastric ulceration, treating hypertension, facilitating the growth of tooth enamel or finger or toe nails, treating glaucoma, treating ocular hypertension, and repairing damage caused by metastatic bone disease using an EP2 selective receptor agonist.

Abstract: To enable a user to readily determine the gauge of the needle of a needle assembly that has a base and a needle protective housing pivotably attached thereto, the needle assembly is injection molded from a color coded molding material which color was preassigned to correspond to the gauge of the needle. As a result, both the base and the protective housing of the needle assembly are the same specific color, and reflect or provide an indication of the given gauge of the needle. The needle sheath that covers the needle prior to use may be made of a plastics material that may be clear, or have the same or a different color than that of the needle assembly.

Abstract: A fluid transfer system has a holder that is made of a cylindrical member having a closed end and an open end. The closed end has fitted thereto a luer and a cannula that extends into the interior of the holder. The holder has a distal portion that has a first cross section and a proximal portion that has a second cross section. The cross section of the distal portion is smaller than the cross section of the proximal portion. The distal and proximal portions are joined by a shoulder. The fluid transfer system also includes an adapter that is inserted to the holder from the open end of the holder. The adapter has a base having a central opening and a cylindrical tube that extends from the central opening. The diameter of the cylindrical tube is slightly smaller than the diameter of the distal portion and is configured to accept a first type of fluid collection store such as a vacuum tube. A non-continuous wall extends from the base of the adapter to surround the cylindrical tube.

Abstract: The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I

Abstract: A safety needle assembly has a collar or ring that is rotatably mounted to a needle hub, which may be connected to a medical device such as a syringe. The needle assembly may be connected to the syringe by the user grasping the needle hub in first and second embodiments, or turning of the needle sheath in other embodiments. In all of the embodiments, the collar of the needle assembly may be rotated by turning the needle sheath, which is designed to interact with the collar. In some of the embodiments, the needle hub likewise interacts with the collar in such a way that by rotating the needle sheath, the needle hub is likewise rotated for connection to a syringe. When an exposed needle is to be covered, after the needle sheath has been removed, a housing connected to the collar is pivotally moved to cover the needle.

Abstract: A safety needle assembly has a needle hub having a proximal portion and a distal portion. Integrally formed from the proximal portion is a ring that surrounds the luer base portion of the needle hub. Windows are provided at the sidewall of the ring to enable a user to see the base portion of the needle hub. At the distal portion of the needle hub there are coaxially formed circumferential flanges. The space between the flanges and the end wall of the ring surrounding the luer end of the needle hub is dimensioned to accept protrusions at the inner surface of the proximal portion of a collar. Once mated to the space at the needle hub, the collar is rotatable, although not freely, about the needle hub. A needle protection housing is connected to the collar and is pivotable to cover the needle that extends from the distal end of the needle hub.

Abstract: This invention provides a process and apparatus for gasifying a particulate solid carbonaceous fuel with a high moisture content, the process comprising: introducing the fuel into one or more pressurized drying vessels without adding water to the fuel; reducing the moisture content of the fuel in the drying vessel(s) to a level suitable for gasification by passing hot product gas through the or each drying vessel such that the fuel particles are entrained in the gas flow, thereby cooling and humidifying the gas; separating the cooled and humidified gas from the fuel; transferring the fuel with reduced moisture content from the or each drying vessel to a gasification vessel, gasifying the fuel in the gasification vessel to produce hot product gas; and introducing at least a portion of the hot product gas into the or each drying vessel. The invention also relates to an integrated process for producing power, especially electric power, from particulate solid carbanaceous fuel.

Abstract: A stylet to be used in combination with a feeding tube assembly for administration or aspiration of fluids to a patient comprising a wire with an elongated loop of variable length and width at its distal end. The width of the loop may be adjusted so as to be greater than the diameter of any apertures in feeding tubes thereby preventing the stylet from exiting the tube assembly and minimizing the possibility of injury to a patient during stylet intubation.